Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Latest test results for lafora in dachshunds
Image mini wire haired dachshund
Latest tests show 8 per cent of dachshunds were affected.
Screenings show 42 per cent are carriers

Recent screenings for lafora's disease in miniature wire-haired dachshunds has revealed that 42 per cent of those tested are carriers of the disease.

The Dachshund Breed Council has reported the findings, which are in line with earlier results. Screenings from last November show 8 per cent of participating dogs were affected with lafora, while 50 per cent were clear.

Lafora's disease is a late-onset form of epilepsy affecting miniature wire-haired dachshunds, as well as beagles and basset hounds. Symptoms include the development of head and neck jerking when the dog is stimulated. Over time, it can lead to blindness and dementia.

The test is offered by Dr Berge Minassian from the Hospital for Sick Children in Canada, and was developed in conjunction with the Wire-Haired Dachshund club.

More than 400 dogs have now been tested and received their results. Of these, 250 were tested with the full DNA affected/carrier/clear test.

The breed council has urged breeders and stud dog owners to offer their support to the testing programme, by only breeding dogs that have received a negative test result for lafora.

Owners of the 8 per cent of dogs found to be affected with lafora have been encouraged to join the active Lafora Support Group and participate in the lafora progression research project, which aims to improve understanding of the management of the disease.

Speaking at the breed council's recent Neurology seminar in Surrey, neurology expert Dr Clare Rusbridge, said 45 per cent of an affected dog's life could be spent suffering debilitating jerking, seizures, confusion, anxiety, possible hallucination, difficulty walking and blindness.

Test results have been supplied to the Kennel Club and a new DNA testing scheme for the disease has been approved.

 

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.